Latest database descriptions

étude épidémiologique du test covid-19 presto chez les agents des collectivités territoriales du Loiret et Orléans Métropole. Corrélation du taux d’IgM en fonction du contact avec le public

April 28 2025

To collect health data about conditions workers and covid-19 serology status in Orleans Metropole, Loiret District and the Centre Val de Loire Region

Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public

April 28 2025

To collect health data about conditions workers and covid-19 serology status in Orleans Metropole, Loiret District and the Centre Val de Loire Region

SANTE, PERCEPTION, PRATIQUES, RELATIONS ET INEGALITES SOCIALES EN POPULATION GENERALE PENDANT LA CRISE COVID-19 – SEROLOGIE (SAPRIS-SERO).

March 25 2025

Based on the collection of capillary blood samples taken by the subjects, SAPRIS-SERO will help to:
• Estimate the cumulative incidence of infection in the general population (objective 1a),
• Characterise the “immune” portion of the population and the durability of immunity (objective 1b).

A non-interventional study to assess the hemoglobin level depending on the comorbidity index in chronic kidney disease (CKD) patients not on dialysi...

December 11 2024

Primary objective : Describe in current medical practice the evolution of hemoglobin levels during the 9-month follow-up in each subgroup defined by the Charlson comorbidity index.

Secondary objectives :
- Describe the characteristics of patients treated with Mircera® in the total population and in the subgroups defined by the Charlson comorbidity index;
- Describe the evolution of the hemoglobin level during the observation period according to the Liu comorbidity index and to ESA resistance factors;
- Describe the changes in the Mircera® dosage during the observation period in the total population and in the subgroups defined by the Charlson comorbidity index;
- Describe the safety profile of Mircera® during the observation period in the total population and in the subgroups defined by the Charlson comorbidity index.

Explore the catalog

The catalog contains the description of the main databases in public health in France

Explore the catalog

Become a contributor

You wish to share the information about your database with researchers and experts in public health?

Become a contributor

Contact us

You have a question? You need more information? 

Send a message

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here